$10.12 0.03 (+0.30%)
11/6/2009 4:00 PM

Omnicell, Inc. (OMCL)

CAPS Rating: 4 out of 5

The Company is a provider of medication control and patient safety solutions for acute care health facilities.

Current Price $10.12 Mkt Cap $320.36M
Open $10.03 P/E Ratio 91.73
Prev. Close $10.09 Div. (Yield) N/A (N/A)
Daily Range $9.94 - $10.33 Volume 62,368
52-Wk Range $6.25 - $13.50 Avg. Daily Vol. 297,000

OMCL News and Commentary

Caps

How do you think OMCL will perform vs the S&P 500?

Add Stock to Watchlist

All Members

159 Outperform
9 Underperform
 

All-Star Members

36 Outperform
3 Underperform
 

Wall Street

1 Outperform
2 Underperform
 

Top OMCL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

pegburt (57.32)
Submitted May 06, 2008

yea, the owner of this company has like 9 kids. he's pretty cool. i think this a good company. seanmcb doesn't know s h i t. he's my 13 year old brother

0 Comments | Reply | Report this Post

CrankyTexan (91.05)
Submitted October 18, 2007

I am a registered nurse who has used Omnicell machines. I hate them. In my opinion, they are a pain in the butt and they slow down my job. When I am rushing to get an item during surgery, the last thing I want to do is swipe my I.D. card, swipe the… More

7 Comments | Reply | Report this Post
OMCL VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about OMCL.

Recs

0
Member Avatar NewlyMinted4Star (< 20) Submitted: 10/26/2009 2:27:40 PM : Outperform Start Price: $10.17 OMCL Score: -0.88

This account tracks the performance of newly minted 4 star stocks - 3 star stocks that recently turned in to 4 star stocks.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar Kinzo (98.83) Submitted: 4/3/2009 4:33:15 PM : Outperform Start Price: $7.90 OMCL Score: -1.78

Finally a solution for a doctor's poor handwriting! Get it automated! In all seriousness however, my best friend's grandfather died after receiving the wrong medication while in the hospital. Having OMCL's medication-management products may have prevented such a terrible thing from happening.

Although they aren't the biggest player in the market (Pyxis is), they are still gobbling up market share since they are ahead of the technology curve. Also, by specializing in medication-management products only, this allows the entire company to focus on its product. Oh and requiring 12-18 month software upgrades is nice too (for additional recurring revenues).

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar megaking (< 20) Submitted: 11/21/2008 7:14:47 PM : Underperform Start Price: $9.70 OMCL Score: +29.84

Large healthcare providers have implemented capital spending freezes which will directly affect Omnicell over the near future and will take at least a couple of years to become remotely profitable. The mobil solution company they recently purchased has proven to to be a failed venture as the quality of the product is lacking and hurting the Omnicell brand.

Report this Post 0 Comments | Reply | Permalink
View All 25 Pitches »

Leaderboard

Find the members with the highest scoring picks in OMCL.

Score Leader

robbg52999

robbg52999 (99.39) Score: +53.02

The Score Leader is the member with the highest score across all their picks in OMCL.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
bp11curious 23.33 10/10/2007 Underperform 3M $29.05 -65.16% -28.07% +37.09
SanDieguito < 20 2/1/2008 Underperform 1Y $20.37 -50.32% -19.50% +30.82
megaking < 20 11/24/2008 Underperform 3Y $9.70 +4.33% +34.17% +29.84 1 Comment
TheCrystalBall 93.32 11/24/2006 Underperform NS $18.25 -44.55% -18.92% +25.63
zulubaby 65.49 9/25/2009 Underperform 5Y $11.99 -15.60% +2.24% +17.84
pocestnik 37.19 4/25/2008 Outperform NS $11.06 -8.50% -20.33% +11.83
issac25 54.92 4/24/2008 Outperform NS $11.04 -8.33% -20.11% +11.77
healthcareinvest 59.85 4/24/2008 Outperform 3M $11.06 -8.50% -19.05% +10.55 1 Comment
ikludge < 20 4/28/2008 Outperform NS $11.25 -10.04% -20.54% +10.50 1 Comment
johncant < 20 4/28/2008 Outperform 3M $11.25 -10.04% -20.54% +10.50 1 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackCarisandCo 78.62 7/24/2009 Outperform NS $11.35 -10.84% +10.74% -21.57
TrackAurigaU.S.A 26.23 5/1/2009 Outperform NS $10.00 +5.20% +26.65% -21.45 10/20/2009 @ $10.52
TrackBBTCapMkts 72.49 1/21/2009 Underperform NS $7.05 +43.55% +34.20% -9.35
TrackAurigaU.S.A 26.23 1/21/2009 Underperform NS $6.41 +36.66% -2.75% -39.42 2/18/2009 @ $8.76
TrackAurigaU.S.A 26.23 12/17/2008 Outperform NS $12.30 -47.89% -9.53% -38.35 1/21/2009 @ $6.41
TrackBBTCapMkts 72.49 2/8/2008 Outperform NS $18.28 -61.71% -39.13% -22.58 1/21/2009 @ $7.00
TrackCarisandCo 78.62 2/4/2008 Outperform NS $20.25 -62.96% -39.86% -23.10 1/30/2009 @ $7.50
TrackBBTCapMkts 72.49 7/20/2007 Outperform NS $23.95 +21.29% +0.65% +20.64 10/10/2007 @ $29.05
TrackBroadpoint.AmTech 73.02 10/30/2006 Outperform NS $18.55 -35.90% +2.51% -38.42 4/22/2008 @ $11.89
TrackMatrix 89.45 9/13/2006 Underperform NS $18.00 -43.78% -13.22% +30.56

Featured Broker Partners